Funding Opportunity RFA-DA-20-013 from the NIH Guide for Grants and Contracts. NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the effects of substance use on PrEP effectiveness and better inform PrEP implementation among substance users. More systematic data are needed regarding the impact of substance use on PrEP management and adherence, along with investigating potential unintended consequences of PrEP use that may be unique to substance users such as changes in harm reduction practices, as well as substance use as a contributor to health risk behaviors with consequences such as increased occurrence of STIs.

Competitive Salary: EMBL: Scientific Programmer / Bioinformatician Location: Germany (DE)

Notice NOT-GM-19-041 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-20-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for technologies with commercialization potential that aim to improve the utilization of wastewater testing for dynamic monitoring of illicit drugs

Funding Opportunity RFA-DA-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit research applications for technologies with commercialization potential that aim to improve the utilization of wastewater testing for dynamic monitoring of illicit drugs

Funding Opportunity PAR-19-281 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications that propose the complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials should be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role).

Funding Opportunity PAR-19-282 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)

Competitive Salary: EMBL: Postdoctoral Fellow Location: Ro Italy (IT)

Depends on Experience: Dana-Farber Cancer Institute: Dana-Farber Cancer Institute seeks a Computational Biologist who will work in the Aguirre laboratory w/in the Hale Center Boston, Massachusetts (US)

Notice NOT-MH-19-029 from the NIH Guide for Grants and Contracts

Notice NOT-HD-19-011 from the NIH Guide for Grants and Contracts

Notice NOT-DA-19-036 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-060 from the NIH Guide for Grants and Contracts

Notice NOT-EB-19-012 from the NIH Guide for Grants and Contracts

Orion Corporation: Orion Corporation is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and market Finland (FI)

Notice NOT-AG-19-024 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-285 from the NIH Guide for Grants and Contracts. The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research on the evolving HIV epidemic in their countries. This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality research environment: Research administration and management; Research integrity oversight; Ethical review of research for the protection of human subjects; Laboratory animal welfare oversight Health sciences library and information services; and Information and communications technology systems (ICT) for research Research infrastructure training programs will maximize previous investments and further strengthen the LMIC institution's research capabilities, and provide more accessible research infrastructure training opportunities to others in their own country and in other LMICs.

Funding Opportunity PAR-19-283 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.

Funding Opportunity PAR-19-284 from the NIH Guide for Grants and Contracts. The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research related to the evolving HIV epidemic in their country.

Wellcome Sanger Institute: Job Reference 83477 Computational Postdoctoral Fellow - Cancer Drug Combinations   Salary range £31,897 - £39,240 (dependent on experience) plu Hinxton, Cambridgeshire, England